Bristol-Myers axes 107 more staffers as it completes an R&D overhaul
Winding down its R&D ops in Wallingford, CT, Bristol-Myers Squibb $BMY has put its remaining workers on notice that it’s axing 107 staffers in the next step of the big revamp.
The biopharma giant said more than a year ago that it would shutter its big facility in the state, while also reversing a decision to try and relocate workers to some other facility in the state.
That reorganization includes expanding operations in Lawrenceville and New Brunswick, NJ and Redwood City, CA, and opening a new research site in Cambridge, MA.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
